Arshed Ali Quyyumi

Scientific Advisor at CardioCell

Dr. Arshed A. Quyyumi is co-director of the Emory Clinical Cardiovascular Research Institute (ECCRI) and an Emory University professor of cardiology. He has been involved in clinical translational research in cardiovascular diseases for more than 25 years. Since 2005, Dr. Quyyumi has been awarded more than $9 million in research funding. He serves on the editorial boards of several national journals, is a member of several Scientific Advisory Boards, and is a reviewer for the NIH-NHLBI Study Sections. He has authored more than 180 peer-reviewed publications and has been an invited speaker and session chair at numerous National and International scientific meetings and conferences. Dr. Quyyumi’s research focus includes vascular biology, angiogenesis, progenitor cell biology, mechanisms of myocardial ischemia, and the role of genetic and environmental risks on vascular disease. He has carried out more than 50 NIH, industry-funded or investigator-initiated projects, including numerous clinical trials. He earned his B.S. in pharmacology and M.D. from the University of London. He completed his residency at Guy’s and Royal Free Hospitals in London, and he received cardiology fellowships at London’s National Heart Hospital, Boston’s Massachusetts General Hospital, and the National Institutes of Health. After completion of his residency and fellowship, he served as a senior investigator, director of the Cardiac Catheterization Laboratory, and other positions in the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) Cardiology Branch.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


CardioCell

CardioCell is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions.


Industries

Employees

1-10

Links